Activity optimization of an undecapeptide analogue derived from a frog-skin antimicrobial peptide

Molecules and Cells

Volumn 31, Issue 1, 2011, Pages 49-54

  Won, Hyung Sik ^a,b   Kang, Su Jin ^a   Choi, Wahn Soo ^b   Lee, Bong Jin ^a,c  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

^c Promeditech Inc   (South Korea)

Author keywords

Activity optimization; Amphipathic helix; Antimicrobial activity; Antimicrobial peptide; Hemolytic activity; Sequence modification

Indexed keywords

OMIGANAN; POLYPEPTIDE ANTIBIOTIC AGENT;

AMINO ACID COMPOSITION; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG ACTIVITY; ESCHERICHIA COLI; HEMOLYSIS; KLEBSIELLA PNEUMONIAE; MICROCOCCUS LUTEUS; NONHUMAN; PROTEIN PROCESSING; PSEUDOMONAS AERUGINOSA; REACTION OPTIMIZATION; SALMONELLA TYPHIMURIUM; SHIGELLA DYSENTERIAE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMOLYSIS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; RANIDAE; SKIN;

ANURA; NEGIBACTERIA; POSIBACTERIA;

EID: 79960019068     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-011-0005-y     Document Type: Article

References (39)

1. Abdel-Wahab, Y.H., Marenah, L., Flatt, P.R., and Conlon, J.M. (2007). Insulin releasing properties of the temporin family of antimicrobial peptides. Protein Pept. Lett. 14, 702-707. (Pubitemid 47416376)
2. Abdel-Wahab, Y.H., Power, G.J., Ng, M.T., Flatt, P.R., and Conlon, J.M. (2008). Insulin-releasing properties of the frog skin peptide pseudin-2 and its [Lys18]-substituted analogue. Biol. Chem. 389, 143-148. (Pubitemid 351170664)
3. Chen, Y., Mant, C.T., Farmer, S.W., Hancock, R.E.W., Vasil, M.L., and Hodges, R.S. (2005). Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/thera-peutic index. J. Biol. Chem. 280, 12316-12329.
4. Chia, C.S., Torres, J., Cooper, M.A., Arkin, I.T., and Bowie, J.H. (2002). The orientation of the antibiotic peptide maculatin 1.1 in DMPG and DMPC lipid bilayers. Support for a pore-forming mechanism. FEBS Lett. 512, 47-51. (Pubitemid 34164449)
5. Chou, H.T., Kuo, T.Y., Chiang, J.C., Pei, M.J., Yang, W.T., Yu, H.C., Lin, S.B., and Chen, W.J. (2008). Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. Int. J. Antimicrob. Agents 32, 130-138.
6. Conlon, J.M. (2008). Reflections on a systematic nomenclature for antimicrobial peptides from the skins of frogs of the family Ranidae. Peptides 29, 1815-1819.
7. Dathe, M., Meyer, J., Beyermann, M., Maul, B., Hoischen, C., and Bienert, M. (2002). General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides. Biochim. Biophys. Acta 1558, 171-186. (Pubitemid 34075532)
8. Diamond, G., Beckloff, N., Weinberg, A., and Kisich, K.O. (2009). The roles of antimicrobial peptides in innate host defense. Curr. Pharm. Des. 15, 2377-2392.
9. Eisenberg, D. (1984). Three-dimensional structure of membrane and surface proteins. Annu. Rev. Biochem. 53, 595-623.
10. Ginsburg, I., and Koren, E. (2008). Are cationic antimicrobial peptides also 'double-edged swords? Expert. Rev. Anti. Infect. Ther. 6, 453-462.
11. Giuliani, A., Pirri, G., and Nicoletto, S.F. (2007). Antimicrobial peptides: an overview of a promising class of therapeutics. Cent. Eur. J. Biol. 2, 1-33. (Pubitemid 46450753)
12. Gordon, Y.J., Romanowski, E.G., and McDermott, A.M. (2005). A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 30, 505-515. (Pubitemid 41113552)
13. Gubern, C., Lopez-Bermejo, A., Biarnes, J., Vendrell, J., Ricart, W., and Fernandez-Real, J.M. (2006). Natural antibiotics and insulin sensitivity: the role of bactericidal/permeability-increasing protein. Diabetes 55, 216-224. (Pubitemid 43343318)
14. Jenssen, H., Hamill, P., and Hancock, R.E.W. (2006). Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491-511. (Pubitemid 44137212)
15. Kim, J.H., Lee, J.O., Jung, J.H., Lee, S.K., You, G.Y., Park, S.J., and Kim, H.S. (2009). Gaegurin-6 stimulates insulin secretion through calcium influx in pancreatic β Rin5mf cells. Regul. Pept. 159, 123-128.
16. Kim, S.R., Hong, M.Y., Park, S.W., Choi, K.H., Yun, E.Y., Goo, T.W., Kang, S.W., Suh, H.J., Kim, I., and Hwang, J.S. (2010). Characterization and cDNA cloning of a cecropin-like antimicrobial peptide, papiliocin, from the swallowtail butterfly, Papilio xuthus. Mol. Cells 29, 419-423.
17. Mader, J.S., and Hoskin, D.W. (2006). Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert. Opin. Investig. Drugs 15, 933-946. (Pubitemid 44177845)
18. Marenah, L., Flatt, P.R., Orr, D.F., Shaw, C., and Abdel-Wahab, Y.H.A. (2006). Skin secretions of Rana saharica frogs reveal antimicrobial peptides esculentins-1 and -1B and brevinins-1E and -2EC with novel insulin releasing activity. J. Endocrinol. 188, 1-9. (Pubitemid 43159805)
19. Nielsen, S.L., Frimodt-Moller, N., Kragelund, B.B., and Hansen, P.R. (2007). Structure-activity study of the antibacterial peptide fallaxin. Protein Sci. 16, 1969-1976. (Pubitemid 47367120)
20. Oren, Z., and Shai, Y. (1998). Mode of action of linear amphipathic α-helical antimicrobial peptides. Biopolymers 47, 451-463.
21. Oyston, P.C.F., Fox, M.A., Richards, S.J., and Clark, G.C. (2009). Novel peptides therapeutics for treatment of infections. J. Med. Microbiol. 58, 977-987.
22. Papo, N., and Shai, Y. (2005). Host defense peptides as new weapons in cancer treatment. Cell. Mol. Life Sci. 62, 784-790. (Pubitemid 40655628)
23. Park, J.M., Jung, J.E., and Lee, B.J. (1994). Antimicrobial peptides from the skin of a Korean frog, Rana rugosa. Biochem. Biophys. Res. Commun. 209, 948-954. (Pubitemid 24381718)
24. Rivas, L., Luque-Ortega, J.R., and Andreu, D. (2009). Amphibian antimicrobial peptides and Protozoa: lessons from parasites. Biochim. Biophys. Acta 1788, 1570-1581.
25. Rubinchik, E., Dugourd, D., Algara, T., Pasetka, C., and Friedland, H.D. (2009). Antimicrobial and antifungal activities of novel cationic antimicrobial peptide, omigana, in experimental skin colonization models. Int. J. Antimicrob. Agents 34, 457-461.
26. Shai, Y. (1999). Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462, 55-70.
27. Shai, Y., and Oren, Z. (2001). From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 22, 1629-1641. (Pubitemid 32918242)
28. Tossi, A., Sandri, L., and Giangaspero, A. (2000). Amphipathic, α- helical antimicrobial peptides. Biopolymers 55, 4-30.
29. Ulvatne, H. (2003). Antimicrobial peptides: potential use in skin infections. Am. J. Clin. Dermatol. 4, 591-595. (Pubitemid 37108418)
30. Won, H.S., Park, S.H., Kim, H.E., Hyun, B., Kim, M., Lee, B., and Lee, B.J. (2002). Effects of a tryptophanyl substitution on the structure and antimicrobial activity of C-terminally truncated gaegurin 4. Eur. J. Biochem. 269, 4367-4374. (Pubitemid 35026023)
31. Won, H.S., Jung, S.J., Kim, H.E., Seo, M.D., and Lee, B.J. (2004). Systematic peptide engineering and structural characterization to search for the shortest antimicrobial peptide analogue of gaegurin 5. J. Biol. Chem. 279, 14784-14791. (Pubitemid 38618867)
32. Won, H.S., Seo, M.D., Jung, S.J., Lee, S.J., Kang, S.J., Son, W.S., Kim, H.J., Park, T.K., Park, S.J., and Lee, B.J. (2006). Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5. J. Med. Chem. 49, 4886-4895.
33. Won, H.S., Kang, S.J., and Lee, B.J. (2009). Action mechanism and structural requirements of the antimicrobial peptides, gaegurins. Biochim. Biophys. Acta 1788, 1620-1629.
34. Yeaman, M.R., and Yount, N.Y. (2003). Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55, 27-55. (Pubitemid 36268398)
35. Zaiou, M. (2007). Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J. Mol. Med. 85, 317-329. (Pubitemid 46452258)
36. Zasloff, M. (1987). Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 84, 5449-5453. (Pubitemid 17129018)
37. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-395. (Pubitemid 34100944)
38. Zelezetsky, I., and Tossi, A. (2006). Alpha-helical antimicrobial peptides-Using a sequence template to guide structure-activity relationships studies. Biochim. Biophys. Acta 1758, 1436-1449. (Pubitemid 44436080)
39. Zhu, W.L., Nan, Y.H., Hahm, K.S., and Shin, S.Y. (2007). Cell selectivity of an antimicrobial peptide melittin diastereomer with Damino acid in the leucine zipper sequence. J. Biochem. Mol. Biol. 40, 1090-1094.